Cravath represented Johnson & Johnson in connection with its October 6, 2010, agreement to acquire, through an affiliate, all outstanding equity of Crucell N.V. that it does not already own, for consideration of approximately €1.75 billion, or €24.75 per share, in a recommended cash tender offer.
The Cravath team included partners Robert I. Townsend and Damien R. Zoubek and associates Brittain A. Rogers and Sarah R. Kahn on corporate matters and partner Eric W. Hilfers and associate Jarrett R. Hoffman on executive compensation and benefits matters.